Dabrafenib + Trametinib for cancer treatmentz

Oxleas NHS Foundation Trust did not have the information requested.

Dear Oxleas NHS Foundation Trust,

Please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment.

A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib:

i) Metastatic Melanoma
ii) Adjuvant Melanoma
iii) BRAF mutated Lung Cancer

I sincerely thank you for taking the time to answer these questions.

Yours faithfully,

David Elder

FOI (OXLEAS NHS FOUNDATION TRUST), Oxleas NHS Foundation Trust

Dear David, 

 

FREEDOM OF INFORMATION ACT 2000 – SECTION 8 REQUEST 

 

Thank you for your request for information dated 29/06/2022. Your request
has been managed under the terms of the Freedom of Information Act 2000.  

  

Please note that Oxleas NHS Foundation Trust do not run acute hospitals or
provide oncology services and the information you have requested is not
held by the Trust. 

 

Oxleas are a community NHS Trust and mental health service provider - for
more information please visit our website at
[1]http://oxleas.nhs.uk/services/. 

 

Following this response, your request for information will be closed. 

 

If you have any queries or concerns or are dissatisfied with the service
you have received in relation to your request, please do not hesitate to
contact us. If you wish to make request a review of the decision, you
should write to the: Information Governance Manager, Julie Lucas via email
at [2][email address] in the first instance. If you remain
unsatisfied with the outcome of your review and wish to make a formal
complaint please address this to the Head of Complaints, Oxleas NHS
Foundation Trust, Pinewood House, Pinewood Place, Dartford DA2 7WG -
Email: [3][email address]     

 

In addition if you are not satisfied with the outcome of your complaint or
review, you may apply directly to the Information Commissioner’s Office
(ICO) for a decision. Generally, the ICO cannot make a decision unless you
have exhausted the complaints procedure provided by the Trust. The ICO can
be contacted at: Information Commissioner's Office, Wycliffe House, Water
Lane, Wilmslow, Cheshire, SK9 5AF (Telephone: 0303 123 1113 or 01625 545
745 - [4]www.ico.org.uk). 

 

Kind regards,     

 

 

Paul Bransgrove

Information Governance Office

E: [5][Oxleas NHS Foundation Trust request email]

Oxleas NHS Foundation Trust | Bracken House | Bracton Lane | Leyton Cross
Road | Dartford | Kent | DA2 7AF

 

══════════════════════════════════════════════════════════════════════════

From: David Elder <[FOI #874404 email]>
Sent: 29 June 2022 10:27
To: FOI (OXLEAS NHS FOUNDATION TRUST) <[email address]>
Subject: Freedom of Information request - Dabrafenib + Trametinib for
cancer treatmentz
 
[You don't often get email from
[FOI #874404 email]. Learn why this is important at
[6]https://aka.ms/LearnAboutSenderIdentific... ]

This message originated from outside of NHSmail. Please do not click links
or open attachments unless you recognise the sender and know the content
is safe.

Dear Oxleas NHS Foundation Trust,

Please answer these questions relating to the usage of Dabrafenib +
Trametinib in cancer treatment.

A)      Over the previous 6 months, how many patients for the following
diseases have been treated with a combination of Dabrafenib + Trametinib:

i)      Metastatic Melanoma
ii)     Adjuvant Melanoma
iii)    BRAF mutated Lung Cancer

I sincerely thank you for taking the time to answer these questions.

Yours faithfully,

David Elder

-------------------------------------------------------------------

Please use this email address for all replies to this request:
[FOI #874404 email]

Is [Oxleas NHS Foundation Trust request email] the wrong address for Freedom of Information
requests to Oxleas NHS Foundation Trust? If so, please contact us using
this form:
[7]https://www.whatdotheyknow.com/change_re...

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[8]https://www.whatdotheyknow.com/help/offi...

For more detailed guidance on safely disclosing information, read the
latest advice from the ICO:
[9]https://www.whatdotheyknow.com/help/ico-...
[10]https://www.whatdotheyknow.com/help/ico-...

Please note that in some cases publication of requests and responses will
be delayed.

If you find this service useful as an FOI officer, please ask your web
manager to link to us from your organisation's FOI page.

show quoted sections